Literature DB >> 27378204

Ligand-targeted bacterial minicells: Futuristic nano-sized drug delivery system for the efficient and cost effective delivery of shRNA to cancer cells.

Mehul Jivrajani1, Manish Nivsarkar2.   

Abstract

In this study, shRNA against VEGFA was packaged in bacterial minicells and surface of minicells was modified with folic acid. Analysis of cellular internalization revealed that folic acid conjugated minicells internalized through receptor mediated endocytosis in folate and PSMA receptor positive KB and LNCaP cells, respectively. In contrast, A549 (folate receptor negative) cells showed minute internalization. In vitro delivery of FAminicellsVEGFA significantly reduced the expression of VEGFA mRNA in KB and LNCaP cells whereas expression of VEGFA remained unaltered in A549 cells. FAminicellsVEGFA significantly reduced tumor volume in mice bearing KB and LNCaP xenograft. On contrary, gradual increase in the tumor volume was recorded in A549 xenograft. FAminicellsVEGFA significantly silenced the VEGFA mRNA in KB and LNCaP xenograft. Expression of VEGFA remained same in FAminicellsVEGFA delivered A549 xenograft. In vivo biodistribution study showed that majority of FAminicellsVEGFA were localized in the tumor followed by intravenous administration.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial minicells; Cancer; Folate receptor targeted delivery; RNA interference; shRNA delivery

Mesh:

Substances:

Year:  2016        PMID: 27378204     DOI: 10.1016/j.nano.2016.06.004

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

1.  An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs).

Authors:  Santiago Viteri; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2018-02

2.  Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits.

Authors:  Michael-Joseph Gorbet; Akansha Singh; Chenkai Mao; Steven Fiering; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

3.  PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.

Authors:  Orielyz Flores; Santimukul Santra; Charalambos Kaittanis; Rania Bassiouni; Amr S Khaled; Annette R Khaled; Jan Grimm; J Manuel Perez
Journal:  Theranostics       Date:  2017-06-24       Impact factor: 11.556

Review 4.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.